Friday 6 November 2026 Export ONC’s income statement to Excel — free account

BeOne Medicines Ltd. - Sponsored ADR

BeOne Medicines Ltd. - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 40.2% from fiscal 2024.

Revenue: +33.8%
EPS: +143.7%
Free cash flow: +33.6%
Total debt: +491.3%

Quarter to September 2026, against a year earlier

407.66 20.41 +5.27%

Follow ONC

Alert me

Market cap: $40.4B
P/E: 65.9×
Fwd P/E: 48.8×
Dividend yield: —
F-score: 7/9
Altman Z: 5.25
Beneish M: −2.73
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

BeOne Medicines Ltd. - Sponsored ADR (ONC) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, BeOne Medicines Ltd. - Sponsored ADR (ONC) trades at a P/E ratio of 65.9×. Over the past ten years it has ranged from 0.0× (September 2025) to 651× (November 2025); the current reading is higher than 95% of that period. That is above the Biotechnology industry median of 10.3× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ONC/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="BeOne Medicines Ltd. - Sponsored ADR P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ONC/metrics/pe-ratio">BeOne Medicines Ltd. - Sponsored ADR (ONC) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	116×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	62.0×	28.41%
Jun 2026	48.3×	(24.37%)
Mar 2026	63.9×	(45.13%)
Dec 2025	116×	(80.18%)
40 more quarters	Free account

Against its own ten years

Low 0.0× High 651×

Ten-year median 0.0×

Current reading's percentile 95

Company	P/E ratio
ROIV Roivant Sciences Ltd. compare	n/m
BNTX BioNTech SE Sponsored ADR compare	n/m
RVMD Revolution Medicines, Inc. compare	n/m
INSM Insmed, Inc. compare	n/m
ARGX argenex SE compare	29.8×
GMAB Genmab A/S Sponsored ADR compare	41.7×
RPRX Royalty Pharma PLC compare	44.8×
INCY Incyte Corporation compare	56.3×
ONC BeOne Medicines Ltd. - Sponsored ADR	65.9×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

BeOne Medicines Ltd. - Sponsored ADR (ONC) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ONC

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ONC

Stockrow Weekly